The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

By Rishika Sadam HYDERABAD, March 19 (Reuters) - India's market for diabetes and weight-loss drugs is set for a shake-up as ...

Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., March 18, 2026 ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that the Institutional Review Board (IRB) at Clinical Pharmacology ...

NASDAQ: MTVA Lili Elston: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we're very pleased you've joined us. The next ...

The drug’s efficacy “looks to be highly competitive” and potentially better than rival pills from Novo and Lilly, BMO Capital ...

Toronto, ON - March 6, 2026 - Cloudcure, a specialized health platform dedicated to improving metabolic health through ...

SANTA ANA, CA - March 16, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...

Dr. Austin Harris, a board-certified cardiothoracic anesthesiologist and the founder of NeuroRelief Ketamine & Infusion Therapy, is redefining the treatment landscape for patients grappling with ...

Altimmune, Inc. (NASDAQ:ALT) Q4 2025 Earnings Call Transcript March 5, 2026 Altimmune, Inc. misses on earnings expectations. Reported EPS is $-0.27191 EPS, expectations were $-0.25. Operator: Good ...

Leerink Global Healthcare Conference 2026 March 10, 2026 10:40 AM EDTCompany ParticipantsBrian Lian - President, CEO ...

Two peer-reviewed studies published in Obesity Pillars report that Ivim Health patients receiving GLP-1 therapy within a comprehensive care protocol achieved up to 26.54% average weight loss in ...